Suchitra Batra
About Suchitra Batra
Suchitra Batra is the Director of M&A Finance at Bristol Myers Squibb in the United States, with extensive experience in biopharmaceutical and management science consulting firms.
Current Role at Bristol Myers Squibb
Suchitra Batra is currently serving as the Director M&A Finance at Bristol Myers Squibb in the United States. She started this role in June 2020. In this capacity, she focuses on mergers and acquisitions within the financial sector of the company.
Professional Experience at Sandoz
From 2017 to 2020, Suchitra Batra worked at Sandoz in Princeton, specializing in Business Development & Alliance Management Finance. During her three-year tenure, she was responsible for managing alliances and financial strategies that supported business development.
Roles at Alcon, a Novartis Company
Suchitra Batra held significant roles at Alcon, a Novartis company, in the Dallas/Fort Worth Area. She served as the Head BPA, US Pharma from 2015 to 2016. Prior to that, from 2013 to 2015, she was the Finance Head - Pharma, Global Clinical & Regulatory Affairs, and Global Medical Affairs, overseeing financial operations in those domains.
Experience at Abraxis BioScience
Suchitra Batra's tenure at Abraxis BioScience, which was acquired by Celgene Corp, spanned from 2006 to 2011. Initially, she worked as a Financial Analyst for two years, followed by a role as Manager, Finance for three years. In these positions, she focused on financial planning, analysis, and management.
Educational Background
Suchitra Batra has an extensive educational background with multiple advanced degrees. She holds a B.S. in Pharmacy from the University of Mumbai. She earned an M.S. in Pharmaceutical Marketing from Saint John's University, an MBA in International Finance from the Peter J. Tobin College of Business at Saint John's University, and a Master's degree in Accounting from Rider University.